OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Company number: 00985158 Charity Number: 261876

Institute of Medical Ethics

Report and financial statements For the year ended 31 December 2025

Institute of Medical Ethics

Reference and administrative information

for the year ended 31 December 2025

Company number 00985158 Charity number 261876

Registered office and operational address

Unit 10, Westway House, 42-44 Bridge Street, Earlestown, Newton-Le-Willows, WA12 9QT

Trustees Trustees, who are also directors under company law, who served during the year and up to the date of this report were as follows:

Dr WM Kong Chair Rev B Vernon Treasurer K Frankland Secretary G Testa Secretary (Resigned 15/9/2025) Prof R Bromley Dr P De Zulueta Prof L Frith Dr R Hart Dr C R Hooper Prof R Huxtable R Mohindra C Patel Dr A Paton Dr C Richie C Whitehouse Dr D Wickins-Drazilova Key management Mr P Greenwood Chief Executive personnel Prof R Gillon Hon President Prof A Campbell Hon Vice President Prof K Boyd Hon Vice President Prof R Higgs Hon Vice President Prof G Stirrat Hon Vice President Prof M Lloyd Hon Vice President Bankers CAF Bank Ltd 25 Kings Hill Avenue Kings Hill West Malling ME19 4TA Independent Jennifer Daniel FCCA DChA, Slade & Cooper Limited examiner Beehive Mill, Jersey St, Manchester, M4 6JG

1

Institute of Medical Ethics

Trustees’ annual report

for the year ended 31 December 2025

The trustees present their report and the unaudited financial statements for the year ended 31 December 2025. Included within the trustees’ report is the directors’ report as required by company law.

Reference and administrative information set out on page 1 forms part of this report. The financial statements comply with current statutory requirements, the memorandum and articles of association and the Statement of Recommended Practice - Accounting and Reporting by Charities: SORP applicable to charities preparing their accounts in accordance with FRS 102.

Objectives and activities

The Objects of the Charity are to advance for the benefit of the public the education of medical practitioners and medical students in the United Kingdom in the impartial understanding and practice of medical and healthcare ethics and law and in the integration of these disciplines into clinical practice.

The Institute of Medical Ethics' policy is to promote interest and study of ethical issues in the provision of healthcare.

The trustees confirm that they have been given the general guidance produced by the Charity Commission on public benefit. The trustees are confident that public benefit is achieved through the education of medical and healthcare ethics and law.

The trustees review the aims, objectives and activities of the charity each year. This report looks at what the charity has achieved and the outcomes of its work in the reporting period. The trustees report the success of each key activity and the benefits the charity has brought to those groups of people that it is set up to help. The review also helps the trustees ensure the charity's aims, objectives and activities remained focused on its stated purposes.

The trustees have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the charity's aims and objectives and in planning its future activities. In particular, the trustees consider how planned activities will contribute to the aims and objectives that have been set.

2

Institute of Medical Ethics

Trustees’ annual report

for the year ended 31 December 2025

Achievements and performance

During the year 2025 the Institute of Medical Ethics continued to promote interest, awareness and analysis of the ethical issues that arise in the provision of health care and are of interest and concern to other disciplines, patients and the public and to encourage their integration into clinical practice for the benefit of the public.

Education

The Institute of Medical Ethics supported the study of medical ethics in health care in a number of ways. These included:

(i) a programme of (a) delivering the grants and awards scheme, providing bursaries or scholarships to medical students undertaking electives, special study modules, intercalated studies or internships, (b) institutional grants, in each case with a focus on health care ethics and (c) a special institutional grant category to support sustainable educational activities;

(ii) an essay competition for Foundation Doctors;

(iii) a face to face student conference in February and a national conference in July 2025 plus a suite of online seminars

(iv) administrative support was provided to the PGBC and UKCEN conferences to widen the scope of bioethics support that the IME is involved in.

Research

The Institute continued to be engaged in medical ethics research, gathering further information about the core content and methods of medical ethics learning, teaching and assessment in the UK and Europe. Members of the Institute's Board of Trustees continued to provide information and assistance on issues related to medical ethics to scholars and the media. The committee aims to build a community of clinical and academic scholars and integrate undergraduate and postgraduate students into this community.

Publication

In partnership with the BMJ Publishing Group, the Institute continued to publish the Journal of Medical Ethics and Medical Humanities. JME has twelve issues per annum and is amongst the most frequently cited medical ethics specialist journals. Brian D. Earp, Lucy Frith and Arianne Shahvisi along with their team continue to receive an increasing number of papers submitted for publication from authors worldwide. Medical Humanities continues to build upon its previous achievements with Sabina Dosani as Editor-in-Chief, taking the journal forwards with increasing financial success. December 2025 saw the successful launch of the JME Practical Bioethics open access journal as a companion publication to the Journal of Medical Ethics.

3

Institute of Medical Ethics

Trustees’ annual report

for the year ended 31 December 2025

Financial review

The principal funding source of the Institute is from the partner share of the journals Medical Humanities and Journal of Medical Ethics. Income from charitable activities which includes membership and journal income has increased slightly from £330,668 in 2024 to £333,950 this year.

Including net gains on investments, the net movement in funds for the year showed a surplus of £43,328 (2024: surplus of £109,882), as shown in the statement of financial activities.

Reserves policy

It is the Governing Body's policy to maintain adequate reserves to enable the Institute to meet any unforeseen costs or to cover any shortfall in expected income.

The level of reserves is monitored and reviewed annually by the officers and members. Unrestricted Reserves at the year-end amounted to £1,237,678 [with an additional £14,900 restricted funds reserved for use on the Lewis W Headley Lecture (by the terms of the donation) and £1,103 on the Robert Hillman bequest restricted for that essay prize]. Members regard these reserves as adequate to fund the development of the Institute’s educational activities in 2026 in the current context of uncertain future income from publication of the journals, and uncertain performance of its investments.

Structure, governance and management

The Trustees are elected by the Members at the Annual General Meeting. In accordance with the Articles of Association Trustees serve a five year term of office and may serve two consecutive terms. .

The officers are elected by the trustees on an annual basis at the meeting immediately following the Annual General Meeting.

The organisation is a charitable company limited by guarantee, incorporated on 21st July 1970 and registered as a charity on 2 February 1971.

The company was established under a memorandum of association which established the objects and powers of the charitable company and is governed under its articles of association.

The trustees are members of the charity, but this entitles them only to voting rights. The trustees have no beneficial interest in the charity.

All trustees give their time voluntarily and receive no benefits from the charity. Any expenses reclaimed from the charity are set out in note 11 to the accounts.

Funds held as custodian trustee on behalf of others

The IME has not acted as custodian trustee during the reporting period.

4

Institute of Medical Ethics

Trustees’ annual report

for the year ended 31 December 2025

Statement of responsibilities of the trustees

The trustees (who are also directors of Institute of Medical Ethics for the purposes of company law) are responsible for preparing the trustees’ annual report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report has been prepared in accordance with the provisions applicable to companies subject to the small companies’ regime of the Companies Act 2006.

The trustees’ annual report has been approved by the trustees on / /2026 and signed on their 18 09 behalf by

Rev B Vernon

Treasurer

5

Institute of Medical Ethics

Trustees’ annual report

for the year ended 31 December 2025

I report to the charity trustees on my examination of the accounts of the company for the year ended 31[st] March 2026 which are set out on pages 7 to 23.

Responsibilities and basis of report

As the charity trustees of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).

Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your company’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner's statement

Since the company’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Association of Chartered Certified Accountants, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of the company as required by section 386 of the 2006 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination; or

  4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Jennifer Daniel FCCA DChA

Slade & Cooper Limited Beehive Mill, Jersey Street Manchester, M4 6JG

Date //202623 09

6

Institute of Medical Ethics

Statement of Financial Activities

(including Income and Expenditure account) for the year ended 31 December 2025

Unrestricted
funds
Note
£
Income from:
Charitable activities:
3
308,641
4
6,943
Investments
5
18,366
Total income
333,950
Expenditure on:
Charitable activities
6
309,693
Total expenditure
309,693
24,257
19,321
9
43,578
Transfer between funds
-
Net movement in funds for the year
43,578
Reconciliation of funds
Total funds brought forward
1,194,100
Total funds carried forward
1,237,678
Other income
Net income/(expenditure) before
net gains/(losses) on
investments
Net gains/(losses) on investments
Net income/(expenditure) for
the year
Restricted
funds
£
-
-
-
Total funds
2025
£
308,641
6,943
18,366
333,950
309,943
309,943
24,007
19,321
43,328
-
43,328
1,210,353
1,253,681
Total funds
2024
£
309,865
7,903
12,900
- 330,668
250 291,771
250 291,771
(250)
-
38,897
70,985
(250)
-
109,882
-
(250)
16,253
109,882
1,100,471
16,003 1,210,353

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

7

Institute of Medical Ethics Company number 00985158

Balance sheet as at 31 December 2025

Note
£
£
Fixed assets
Tangible assets
13
5,076
Investments
14
552,728
Total fixed assets
557,804
Current assets
Debtors
15
306,173
Cash at bank and in hand
16
414,000
Total current assets
720,173
Liabilities
Creditors: amounts falling
due in less than one year
17
(24,296)
Net assets
1,253,681
The funds of the charity:
Restricted income funds
18
16,003
Unrestricted income funds
19
1,237,678
Total charity funds
1,253,681
2025
Note
£
£
Fixed assets
Tangible assets
13
5,076
Investments
14
552,728
Total fixed assets
557,804
Current assets
Debtors
15
306,173
Cash at bank and in hand
16
414,000
Total current assets
720,173
Liabilities
Creditors: amounts falling
due in less than one year
17
(24,296)
Net assets
1,253,681
The funds of the charity:
Restricted income funds
18
16,003
Unrestricted income funds
19
1,237,678
Total charity funds
1,253,681
2025
£
£
4,626
478,407
483,033
275,261
472,333
747,594
(20,274)
1,210,353
16,253
1,194,100
1,210,353
2024
£
£
4,626
478,407
483,033
275,261
472,333
747,594
(20,274)
1,210,353
16,253
1,194,100
1,210,353
2024
557,804 483,033
1,253,681 1,210,353
16,003
1,237,678
16,253
1,194,100
1,253,681 1,210,353

For the year in question, the company was entitled to exemption from an audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

These accounts are prepared in accordance with the special provisions of part 15 of the Companies Act 2006 relating to small companies and in accordance with FRS102 SORP, and constitute the annual accounts required by the Companies Act 2006 and are for circulation to members of the company.

The notes on pages 9 to 23 form part of these accounts.

Approved by the trustees on ___/ ___ /2026 and signed on their behalf by18 09

Rev B Vernon (Treasurer)

8

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025

1 Accounting policies

The principal accounting policies adopted, judgments and key sources of estimation uncertainty in the preparation of the financial statements are as follows:

a Basis of preparation

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102), second edition - October 2019 (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006 and UK Generally Accepted Accounting Practice.

The charity has applied the exemption available to small charities in the Charities SORP (FRS 102) and does not include a Statement of Cash Flows in these Financial Statements.

Institute of Medical Ethics meets the definition of a public benefit entity under FRS102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy note.

b Preparation of the accounts on a going concern basis

The trustees consider that there are no material uncertainties about the charitable company's ability to continue as a going concern.

There are no key judgments which the trustees have made which have a significant effect on the accounts.

The trustees do not consider that there are any sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities within the next reporting period.

9

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

c Income

Income is recognised when the charity has entitlement to the funds, any performance conditions attached to the item(s) of income have been met, it is probable that the income will be received and the amount can be measured reliably.

Income from government and other grants, whether ‘capital’ grants or ‘revenue’ grants, is recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received and the amount can be measured reliably and is not deferred.

For legacies, entitlement is taken as the earlier of the date on which either: the charity is aware that probate has been granted, the estate has been finalised and notification has been made by the executor(s) to the charity that a distribution will be made, or when a distribution is received from the estate. Receipt of a legacy, in whole or in part, is only considered probable when the amount can be measured reliably and the charity has been notified of the executor’s intention to make a distribution. Where legacies have been notified to the charity, or the charity is aware of the granting of probate, and the criteria for income recognition have not been met, then the legacy is a treated as a contingent asset and disclosed if material.

Income received in advance of a provision of a specified service is deferred until the criteria for income recognition are met.

d Donated services and facilities

Donated professional services and donated facilities are recognised as income when the charity has control over the item, any conditions associated with the donated item have been met, the receipt of economic benefit from the use by the charity of the item is probable and that economic benefit can be measured reliably. In accordance with the Charities SORP (FRS 102), general volunteer time is not recognised; refer to the trustees’ annual report for more information about their contribution.

On receipt, donated professional services and donated facilities are recognised on the basis of the value of the gift to the charity which is the amount the charity would have been willing to pay to obtain services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt.

e Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the Bank.

10

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

f Fund accounting

Unrestricted funds are available to spend on activities that further any of the purposes of charity.

Designated funds are unrestricted funds of the charity which the trustees have decided at their discretion to set aside to use for a specific purpose.

Restricted funds are donations which the donor has specified are to be solely used for particular areas of the charity’s work or for specific projects being undertaken by the charity.

g Expenditure and irrecoverable VAT

Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably. Expenditure on charitable activities includes the costs of activities undertaken to further the purposes of the charity and their associated support costs.

Irrecoverable VAT is charged as a cost against the activity for which the expenditure was incurred.

h Allocation of support costs

Support costs are those functions that assist the work of the charity but do not directly undertake charitable activities. Support costs include back office costs, finance, personnel, payroll and governance costs which support the charity's programmes and activities.

i Operating leases

Operating leases are leases in which the title to the assets, and the risks and rewards of ownership, remain with the lessor. Rental charges are charged on a straight line basis over the term of the lease.

j Tangible fixed assets

Individual fixed assets costing £400 or more are capitalised at cost and are depreciated over their estimated useful economic lives on the following basis:

Fixtures and fittings 33% Straight line Office equipment 25% Reducing balance

11

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

k Fixed asset investments

Investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing quoted market price. The statement of financial activities includes the net gains and losses arising on revaluation and disposals throughout the year.

The Charity does not acquire put options, derivatives or other complex financial instruments.

The main form of financial risk faced by the charity is that of volatility in equity markets and investment markets due to wider economic conditions, the attitude of investors to investment risk, and changes in sentiment concerning equities and within particular sectors or sub sectors.

l Debtors

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

m Cash at bank and in hand

Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

n Creditors and provisions

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

o Financial instruments

The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

12

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

p Pensions

Employees of the charity are entitled to join a defined contribution ‘money purchase’ scheme. The charity’s contribution is restricted to the contributions disclosed in note 10. There were outstanding contributions of £528 at the year end.

2 Legal status of the charity

The charity is a company limited by guarantee registered in England and Wales and has no share capital. In the event of the charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the charity. The registered office address is disclosed on page 1.

3 Income from charitable activities

Membership and Journal of Medical Ethics
Grant (Wellcome Trust)
Total
4
Other income
Conference income
Non-primary purpose trading
2025
£
308,641
-
308,641
2025
£
4,906
2,037
6,943
2024
£
287,604
22,261
309,865
2024
£
7,445
458
7,903

All income from other trading activities is unrestricted.

5 Investment income

Income from investments and bank deposits 2025
£
18,366
18,366
2024
£
12,900
12,900

All of the charity's investment income arises from money held in interest bearing deposit accounts. All investment income is unrestricted.

13

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

6 Analysis of expenditure on charitable activities

Staff costs
Unrestricted funds
Restricted funds
Total 2025
Grant funding of
activities (see note 7)
Share of support costs
(see note 8)
Share of governance
costs (see note 8)
Total
Analysis by fund
£
29,846
29,846
46,722
84,126
8,294
168,988
168,988
-
168,988
Education,
research,
community of
teachers &
organisational
development
£
15,951
15,951
-
44,980
-
60,931
60,681
250
60,931
Grants &
membership
£
520
520
-
1,506
-
2,026
2,026
-
2,026
Regional
groups
£
6,998
6,998
-
19,761
-
26,759
26,759
-
26,759
Postgrad
student
committee &
Student activity
£
7,281
7,281
-
20,514
-
27,795
27,795
-
27,795
Staff
£
6,130
6,130
-
17,314
-
23,444
23,444
-
23,444
JME
Total 2025
£
66,726
66,726
46,722
188,201
8,294
309,943
309,693
250
309,943
Total 2024
£
69,686
69,686
37,154
176,178
8,753
291,771
291,521
250
291,771

14

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

6 Analysis of expenditure on charitable activities (continued)

Previous reporting period

Staff costs
Unrestricted funds
Restricted funds
Share of support costs
(see note 8)
Share of governance
costs (see note 8)
Total
Total 2024
Grant funding of
activities (see note 7)
Analysis by fund
£
32,293
32,293
37,154
81,041
8,753
159,241
159,241
-
159,241
Education,
research,
community of
teachers &
organisational
development
£
15,582
15,582
-
38,759
-
54,341
54,091
250
54,341
Grants &
membership
£
528
528
-
1,762
-
2,290
2,290
-
2,290
Regional
groups
£
7,520
7,520
-
19,380
-
26,900
26,900
-
26,900
Postgrade
student
committee
& Student
activity
£
7,391
7,391
-
19,380
-
26,771
26,771
-
26,771
Staff
£
6,372
6,372
-
15,856
-
22,228
22,228
-
22,228
JME40
Conference
& ICCEC
Total 2024
£
69,686
69,686
37,154
176,178
8,753
291,771
291,521
250
291,771
Total 2023
£
57,678
57,678
78,403
148,721
7,039
291,841
291,591
250
291,841

15

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

7 Grants payable

Education, research, community of teachers & organisational development

Education, research, community of teachers & organisational
Grants to institutions:
Grants to individuals
development
2025
£
10,564
36,158
46,722
2024
£
(1,095)
38,249
37,154

2024 grants to institutions were offset by the return of a grant awarded in 2023.

8 Analysis of governance and support costs

Current reporting period
Staff costs
Depreciation
Conference costs
JME 50 anniversary project
Meeting & travelling costs
Office expenses
Prizes and awards
Literature & brochures
Accountancy and legal fees
Loss on investment
Previous reporting period
Staff costs
Depreciation
Conference costs
Meeting & travelling costs
Office expenses
Prizes and awards
Literature & brochures
Accountancy
Loss on investment
Support
£
17,133
2,013
44,290
20,000
28,715
36,942
250
18,498
20,360
-
188,201
Support
£
33,878
2,094
50,145
28,980
37,361
250
23,470
-
-
176,178
Governance
£
-
-
-
-
67
-
-
-
8,227
-
8,294
Governance
£
-
-
-
822
-
-
-
7,931
-
8,753
Total 2025
£
17,133
2,013
44,290
20,000
28,782
36,942
250
18,498
28,587
-
196,495
Total 2024
£
33,878
2,094
50,145
29,802
37,361
250
23,470
7,931
-
184,931

16

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

9 Net income/(expenditure) for the year

This is stated after charging/(crediting):
Depreciation
Independent examiner - accountancy fees
Staff costs
Staff costs during the year were as follows:
Wages and salaries
Social security costs
Pension costs
Allocated as follows:
Charitable activities
Support costs
2025
£
2,013
3,025
2025
£
78,469
1,135
3,381
82,985
66,726
16,259
82,985
2024
£
2,094
2,850
2024
£
80,301
2,316
20,947
103,564
69,686
33,878
103,564

10 Staff costs

The increase in pension costs during 2024 was to balance and write-off a cumulative liability reflected in the accounts for several years.

No employees have employee benefits in excess of £60,000 (2024: Nil).

The average number of staff employed during the period was 3 (2024: 3).

The key management personnel of the charity comprise the trustees and the Chief Executive Officer. The total employee benefits of the key management personnel of the charity were £58,741 (2024: £56,197).

17

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

11 Trustee remuneration and expenses, and related party transactions

Neither the management committee nor any persons connected with them received any remuneration during the year (2024: Nil).

2 (2024: 6) trustees received travel and subsistence expenses during the year of £67 (2024: £822).

There are no donations from related parties which are outside the normal course of business and no restricted donations from related parties.

No trustee or other person related to the charity had any personal interest in any contract or transaction entered into by the charity, including guarantees, during the year (2024: nil).

12 Corporation tax

The charity is exempt from tax on income and gains falling within Chapter 3 of Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects. No tax charges have arisen in the charity.

13 Fixed assets: tangible assets

Cost
Additions
Disposals
Depreciation
Charge for the year
Disposals
Net book value
At 31 December 2024
At 1 January 2025
At 31 December 2025
At 31 December 2025
At 1 January 2025
At 31 December 2025
Fixtures &
fittings
£
185
-
-
185
184
1
-
185
-
1
Office
equipment
£
23,174
2,463
(3,089)
22,548
18,549
2,012
(3,089)
17,472
5,076
4,625
£
23,359
2,463
(3,089)
Total
22,733
18,733
2,013
(3,089)
17,657
5,076
4,626

18

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

14 Investments

Add: additions to investments at cost
Add net gain/(loss) on revaluation
Investments are all carried at fair value.
15
Debtors
Trade debtors
Other debtors
Prepayments and accrued income
16
Cash at bank and in hand
Cash at bank and on hand
17
Creditors: amounts falling due within one year
Trade creditors
Other creditors and accruals
Deferred income
Taxation and social security costs
Market value at the end of the year
Market value at the start of the year
Cash held by investment broker pending
reinvestment
2025
£
478,407
55,000
19,321
552,728
25,424
2025
£
297,052
3,072
6,049
306,173
2025
£
414,000
414,000
2025
£
4,827
4,260
13,960
1,249
24,296
2024
£
407,422
-
70,985
478,407
21,063
2024
£
271,190
-
4,071
275,261
2024
£
472,333
472,333
2024
£
13,512
3,791
-
2,971
20,274

19

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

18 Analysis of movements in restricted funds

Total
Total
Name of
restricted fund
Previous reporting
period
Lewis W Headley Lecture
Robert Hillman Bequest
Lewis W Headley
Lecture
Robert Hillman Bequest
Current reporting
period
Balance at 1
January
2025
£
1,353
14,900
16,253
Balance at 1
January
2024
£
1,603
14,900
16,503
Description,
Income
Expenditure
Transfers
£
£
£
-
(250)
-
-
-
-
-
(250)
-
Income
Expenditure
Transfers
£
£
£
-
(250)
-
-
-
-
-
(250)
-
nature and purposes of the fund
Balance at
31
December
2025
£
1,103
14,900
16,003
Balance at
31
December
2024
£
1,353
14,900
16,253

Robert Hillman Bequest The Robert Hillman Bequest is restricted for use on the essay prize.

Lewis W Headley Lecture This fund is restricted for use on the Lewis W Headley Lecture.

20

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

19 Analysis of movement in unrestricted funds

General fund
Name of
unrestricted fund
General fund
General fund
Current reporting
period
Previous reporting
period
Balance at
1 January
2025
Income
Expenditure
Transfers
£
£
£
£
1,194,100
333,950
(290,372)
-
1,194,100
333,950
(290,372)
-
Balance at
1 January
2024
Income
Expenditure
Transfers
£
£
£
£
1,083,968
330,668
(220,536)
-
1,083,968
330,668
(220,536)
-
Description, nature and purposes of the fund
The free reserves after allowing for all designated funds
Balance at
31
December
2025
£
1,237,678
1,237,678
Balance at
31
December
2024
£
1,194,100
1,194,100

21

20 Analysis of net assets between funds

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

Current reporting period
Tangible fixed assets
Fixed asset investments
Net current assets/(liabilities)
Total
Previous reporting period
Tangible fixed assets
Fixed asset investments
Net current assets/(liabilities)
Total
General
fund
£
5,076
552,728
679,874
1,237,678
General
fund
£
4,626
478,407
711,067
1,194,100
Designated
funds
£
-
-
-
-
Designated
funds
£
-
-
-
-
Restricted
funds
£
-
-
16,003
16,003
Restricted
funds
£
-
-
16,253
16,253
Total
2025
£
5,076
552,728
695,877
1,253,681
Total
2024
£
4,626
478,407
727,320
1,210,353

22

Institute of Medical Ethics

Notes to the accounts for the year ended 31 December 2025 (continued)

21 Prior year Statement of Financial Activities (including Income and Expenditure account)

Income from:
Charitable activities:
Investments
Total income
Expenditure on:
Charitable activities
Total expenditure
Transfer between funds
Net movement in funds for the year
Reconciliation of funds
Total funds brought forward
Total funds carried forward
Realised gains/(losses) on investments
Net income/(expenditure) for the
year
Other income
Net income/(expenditure) before
net gains/(losses) on investments
Unrestricted
funds
£
309,865
7,903
12,900
330,668
291,521
291,521
39,147
70,985
110,132
-
110,132
1,083,968
1,194,100
Restricted
funds
£
-
-
-
-
250
250
(250)
-
(250)
-
(250)
16,503
16,253
Total funds
2024
£
309,865
7,903
12,900
330,668
291,771
291,771
38,897
70,985
109,882
-
109,882
1,100,471
1,210,353
Total funds
2023
£
323,782
(6,171)
7,517
325,128
252,327
252,327
72,801
(39,514)
33,287
-
33,287
1,067,184
1,100,471

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

23